We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
AUM
$2.11B
AUM Growth
-$591M
Cap. Flow
-$628M
Cap. Flow %
-29.79%
Top 10 Hldgs %
7.53%
Holding
1,996
New
675
Increased
311
Reduced
433
Closed
572

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$17M
2
MA icon
Mastercard
MA
+$16.2M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$13.5M
4
GE icon
GE Aerospace
GE
+$12.2M
5
VZ icon
Verizon
VZ
+$11.8M

Sector Composition

Rank Sector Weight
1 Technology 14.48%
2 Healthcare 13.48%
3 Consumer Discretionary 12.47%
4 Industrials 11.01%
5 Energy 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PES
1076
DELISTED
Pioneer Energy Services Corp.
PES
$287K 0.01%
132,703
+122,088
+1,150% +$315K
PLOW icon
1077
Douglas Dynamics
PLOW
$992M
$286K 0.01%
+13,609
New +$298K
MGEE icon
1078
MGE Energy Inc
MGEE
$3.03B
$285K 0.01%
+6,161
New +$264K
GTE icon
1079
Gran Tierra Energy
GTE
$236M
$284K 0.01%
+13,130
New +$312K
AVX
1080
DELISTED
AVX Corporation
AVX
$284K 0.01%
+23,399
New +$309K
SIGM
1081
DELISTED
Sigma Designs Inc
SIGM
$282K 0.01%
+44,647
New +$353K
OSIR
1082
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$280K 0.01%
+27,049
New +$367K
MTD icon
1083
Mettler-Toledo International
MTD
$28.1B
$279K 0.01%
823
-6,082
-88% -$1.95M
INSY
1084
DELISTED
Insys Therapeutics, Inc.
INSY
$279K 0.01%
9,761
+1,161
+14% +$32.2K
PACW
1085
DELISTED
PacWest Bancorp
PACW
$277K 0.01%
6,441
-48,542
-88% -$2.18M
NPK icon
1086
National Presto Industries
NPK
$870M
$276K 0.01%
+3,338
New +$289K
SCAI
1087
DELISTED
Surgical Care Affiliates, Inc.
SCAI
$276K 0.01%
+6,944
New +$242K
KG
1088
Kestrel Group
KG
$66.1M
$275K 0.01%
+923
New +$279K
AUB icon
1089
Atlantic Union Bankshares
AUB
$6.05B
$273K 0.01%
+10,836
New +$279K
CATM
1090
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$273K 0.01%
+8,136
New +$283K
RP
1091
DELISTED
RealPage, Inc.
RP
$273K 0.01%
12,189
-3,000
-20% -$61K
AXAS
1092
DELISTED
Abraxas Petroleum Corp
AXAS
$272K 0.01%
+12,837
New +$353K
GNCMA
1093
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$272K 0.01%
+13,768
New +$273K
ABAX
1094
DELISTED
Abaxis Inc
ABAX
$272K 0.01%
+4,903
New +$248K
PACB icon
1095
Pacific Biosciences
PACB
$435M
$269K 0.01%
20,519
+4,050
+25% +$36.3K
HSII
1096
DELISTED
Heidrick & Struggles
HSII
$268K 0.01%
9,877
-8,100
-45% -$212K
TLPH icon
1097
Talphera
TLPH
$68M
$268K 0.01%
+3,488
New +$299K
FCE.A
1098
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$266K 0.01%
12,168
-63,081
-84% -$1.37M
ACAD icon
1099
Acadia Pharmaceuticals
ACAD
$4.51B
$265K 0.01%
7,437
-86,032
-92% -$3.03M
ADAP
1100
DELISTED
Adaptimmune Therapeutics
ADAP
$265K 0.01%
+22,000
New +$215K

Similar funds

A.R.T. Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, A.R.T. Advisors held 1,996 positions worth $2.11B, down 22% from $2.7B the previous quarter. Its ten largest holdings account for 7.5% of the portfolio.

A.R.T. Advisors withdrew a net $628M in Q4 2015, closing 572 positions and reducing 433 holdings. Its most notable exit was Monsanto Co, an estimated $23.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, A.R.T. Advisors opened a new position in PepsiCo worth $17M.

  • A.R.T. Advisors's largest Q4 2015 buy was PepsiCo: 170,163 shares worth $17M.
  • A.R.T. Advisors added most to Cognizant in Q4 2015, an estimated $11.8M increase.
  • A.R.T. Advisors's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $23.2M.
  • A.R.T. Advisors fully exited Monsanto Co in Q4 2015, selling an estimated $23.7M.
  • A.R.T. Advisors's ten largest holdings make up 7.5% of its $2.11B portfolio in Q4 2015.
  • A.R.T. Advisors opened 675 new positions and closed 572 in Q4 2015.
  • A.R.T. Advisors's portfolio value fell 22% quarter-over-quarter to $2.11B.

Based on A.R.T. Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.